Cargando…
Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study
OBJECTIVE: Intrahepatic cholestasis of pregnancy (ICP) is a common pregnancy-related liver disease and is associated with an increased risk of adverse neonatal outcomes. Ursodeoxycholic acid (UDCA) is the most effective treatment. This study was aimed at investigating the adverse outcomes of ICP and...
Autores principales: | Luo, Mingjuan, Tang, Mengyang, Jiang, Feng, Jia, Yizhen, Chin, Robert Kien Howe, Liang, Wei, Cheng, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016576/ https://www.ncbi.nlm.nih.gov/pubmed/33833795 http://dx.doi.org/10.1155/2021/6641023 |
Ejemplares similares
-
Distribution of endotoxin in maternal and fetal body with intrahepatic cholestasis of pregnancy and its association with adverse fetal outcome
por: Huang, Xiaomei, et al.
Publicado: (2022) -
Impaired fetal adrenal function in intrahepatic cholestasis of pregnancy
por: Wang, Chunfang, et al.
Publicado: (2011) -
Recurrent Intrahepatic Cholestasis of Pregnancy with History of Fetal Demise
por: Mulu, Zelalem, et al.
Publicado: (2023) -
Risk factors associated with cesarean section and adverse fetal outcomes in intrahepatic cholestasis of pregnancy
por: Kong, Chengcai, et al.
Publicado: (2023) -
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy
por: Granese, Roberta, et al.
Publicado: (2023)